Arcxis Gets Investment from In-Q-Tel
March 12, 2009
Arcxis Gets Investment from In-Q-Tel
Arcxis received an undisclosed investment from In-Q-Tel, which it will use to accelerate development and commercialization of its nucleic acid sample preparation platform and diagnostic consumable product line.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Arcxis Receives Investment from IQT for Sample Prep, Molecular Dx Development
February 4, 2010 / PCR Insider - Industry Briefs
February 5, 2009 / ProteoMonitor - In-Q-Tel Invests in Claremont to Accelerate Sample Prep Platform
October 17, 2012 / GenomeWeb Daily News - Astute Medical Completes $40M Series C Funding Round
June 8, 2012 / ProteoMonitor - In-Q-Tel Supports Development of OpGen's Microbial Genome Mapping System, Migration to Cloud
May 8, 2012 / In Sequence